Topic Highlight
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Nov 14, 2014; 20(42): 15564-15579
Published online Nov 14, 2014. doi: 10.3748/wjg.v20.i42.15564
Figure 1
Figure 1 Survival in patients with pancreatic cancer who undergo neoadjuvant therapy vs a surgery-first approach. Survival curves for patients who complete multimodality therapy, inclusive of chemoradiation and curative-intent resection, incorporating major postoperative complications or those who never undergo resection.